Evidence map›Paper›PMID 2538542›Full record

ArticleThe Journal of experimental medicine1989

Mature T-lineage leukemia with growth factor-induced multilineage differentiation.

F Griesinger, D C Arthur, R Brunning, J L Parkin, A C Ochoa, W J Miller, C W Wilkowski, J M Greenberg, C Hurvitz, J H Kersey

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in The Journal of experimental medicine, 1989. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

F GriesingerDepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis 55455.
D C Arthur
R Brunning
J L Parkin
A C Ochoa
W J Miller
C W Wilkowski
J M Greenberg
C Hurvitz
J H Kersey
University of Minnesota · US

Funding

RETROVIRAL TRANSDUCTION OF LYMPHOCYTES FOR ANTI-LYMPHOMA THERAPYP01CA021737 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MILLER, WESLEY J · 1985 to 1997
–
DIFFERENTIATION OF IMMUNE SYSTEM CELL SURFACE ANTIGENSR01CA025097 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI KERSEY, JOHN H · 1985 to 1988
–
NCI NIH HHS CA-21737NCI NIH HHS CA-25097
6 · The paper itself

Abstract

We report an acute T-lymphoblastic leukemia with a predominantly mature CD3+ CD7+ WT31+ phenotype that was induced to differentiate into different cell lineages by various recombinant human growth factors. In the presence of IL-3 or GM-CSF, the leukemic cells gave rise to myeloid and monocytic cells including terminally differentiated, partially functional, segmented neutrophilic granulocytes as assessed by morphologic, cytochemical, immunophenotypic, and functional criteria. In the presence of IL-2, leukemic granulated lymphoid cells exhibiting MHC-unrestricted cytotoxicity and expressing a CD2+ CD3+ CD5+ CD7+ CD8+ CD33+ WT31+ Leu19+ phenotype arose. Leukemic cell cultures initiated with IL-3 yielded growth factor-independent cells with a mixed lineage phenotype and morphologic and cytochemical evidence of immature blasts. These were T lymphocyte and myeloid surface antigen (CD2,CD3,CD5,CD7,CD13,CD33,WT31) positive. Identical rearrangements of the constant region of the TCR-delta gene and of the joining regions of the TCR-beta, -gamma, and -delta genes were observed in the fresh and all cultured leukemic cells, indicating that they were derived from the same malignant clone. Consistent with the molecular genetic data, the cytogenetic analyses of the GM-CSF-, IL-3-cultured and the growth factor-independent leukemic cells showed the presence of multiple, closely related abnormal clones, all of which had an interstitial deletion of part of the long arm of chromosome 6 and a complex 1;10;12 translocation. In conclusion, these data demonstrate the involvement of a multipotent leukemic precursor cell in this predominantly mature CD2+ CD3+ CD5+ CD7+ WT31+ T-ALL. This multipotent leukemic precursor may be susceptible to various growth factors and respond with ordered differentiation and maturation.

Indexed as

AdultAntigens, SurfaceCell DifferentiationCell NucleusColony-Stimulating FactorsCytoplasmGranulocyte-Macrophage Colony-Stimulating FactorGrowth SubstancesHematopoietic Stem CellsHistocytochemistryHumansInterleukin-2Interleukin-3KaryotypingLeukemia-Lymphoma, Adult T-CellMaleAntigens, SurfaceColony-Stimulating FactorsGranulocyte-Macrophage Colony-Stimulating FactorGrowth SubstancesInterleukin-2Interleukin-3PeroxidaseReceptors, Antigen, T-Cell

Identifiers

PMID2538542
PMCPMC2189262
OpenAlexW2150635280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.